ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 |
(State or other jurisdiction of incorporation or organization) |
(I.R.S. Employer Identification Number) | |
(Address of principal executive offices) |
(Zip Code) |
Title of Each Class: |
Trading Symbol(s) |
Name of Each Exchange on Which Registered: | ||
one-half of one redeemable warrant |
||||
Large accelerated filer | ☐ | Accelerated filer | ☐ | |||
☒ | Smaller reporting company | |||||
Emerging growth company |
• | our ability to select an appropriate target business or businesses; |
• | our ability to complete our initial business combination; |
• | our expectations around the performance of the prospective target business or businesses; |
• | our success in retaining or recruiting, or changes required in, our officers, key employees or directors following our initial business combination; |
• | our officers and directors allocating their time to other businesses; |
• | our officers and directors potentially having conflicts of interest with our business or in approving our initial business combination; |
• | our potential ability to obtain additional financing to complete our initial business combination; |
• | our pool of prospective target businesses; |
• | our ability to consummate an initial business combination due to the uncertainty resulting from the COVID-19 pandemic; |
• | the ability of our officers and directors to generate a number of potential business combination opportunities; |
• | our public securities’ potential liquidity and trading; |
• | the lack of a market for our securities; |
• | the use of proceeds not held in the Trust Account (defined below in Item 1 under the heading “Introduction”) or available to us from interest income on the Trust Account balance; |
• | the Trust Account not being subject to claims of third parties; |
• | our financial performance following our initial public offering; and |
• | the other risks and uncertainties discussed in “Risk Factors” and elsewhere in this Annual Report on Form 10-K. |
• | We are a blank check company with no operating history and no revenues, and you have no basis on which to evaluate our ability to achieve our business objective. |
• | Our stockholders may not be afforded an opportunity to vote on our proposed initial business combination, which means we may complete our initial business combination even though a majority of our stockholders do not support such a combination. |
• | Your only opportunity to affect the investment decision regarding a potential business combination may be limited to the exercise of your right to redeem your shares from us for cash. |
• | If we seek stockholder approval of our initial business combination, our initial stockholder and management team have agreed to vote in favor of such initial business combination, regardless of how our public stockholders vote. |
• | The ability of our public stockholders to redeem their shares for cash may make our financial condition unattractive to potential business combination targets, which may make it difficult for us to enter into a business combination with a target. |
• | The requirement that we complete our initial business combination by March 24, 2023 may give potential target businesses leverage over us in negotiating a business combination and may limit the time we have in which to conduct due diligence on potential business combination targets, in particular as we approach our dissolution deadline, which could undermine our ability to complete our initial business combination on terms that would produce value for our stockholders. |
• | Our search for a business combination, and any target business with which we ultimately consummate a business combination, may be materially adversely affected by the coronavirus (COVID-19) outbreak and the status of debt and equity markets. |
• | If we seek stockholder approval of our initial business combination, our initial stockholder, directors, executive officers, advisors and their affiliates may elect to purchase shares or public warrants from public stockholders, which may influence a vote on a proposed business combination and reduce the public “float” of our Class A common stock. |
• | If a stockholder fails to receive notice of our offer to redeem our public shares in connection with our initial business combination, or fails to comply with the procedures for tendering its shares, such shares may not be redeemed. |
• | Nasdaq may delist our securities from trading on its exchange, which could limit investors’ ability to make transactions in our securities and subject us to additional trading restrictions. |
• | We face several risks relating to increased regulatory and third-party scrutiny of SPACs. |
• | We are dependent upon our executive officers and directors and their departure could adversely affect our ability to operate. |
• | Our sponsor, officers and directors may have conflicts of interest in various forms as a result of, among other things, their fiduciary or contractual obligations to other entities, their interests in a potential business combination and the fact that they will lose their investment in us if our initial business combination is not completed. |
• | restrictions on the nature of our investments; and |
• | restrictions on the issuance of securities, |
• | registration as an investment company with the SEC; |
• | adoption of a specific form of corporate structure; and |
• | reporting, record keeping, voting, proxy and disclosure requirements and other rules and regulations that we are not subject to. |
• | may significantly dilute the equity interest of investors in the Public Offering; |
• | may subordinate the rights of holders of Class A common stock if shares of preferred stock are issued with rights senior to those afforded our Class A common stock; |
• | could cause a change in control if a substantial number of shares of Class A common stock is issued, which may affect, among other things, our ability to use our net operating loss carry forwards, if any, and could result in the resignation or removal of our present officers and directors; and |
• | may adversely affect prevailing market prices for our units, Class A common stock and/or warrants. |
• | default and foreclosure on our assets if our operating revenues after an initial business combination are insufficient to repay our debt obligations; |
• | acceleration of our obligations to repay the indebtedness even if we make all principal and interest payments when due if we breach certain covenants that require the maintenance of certain financial ratios or reserves without a waiver or renegotiation of that covenant; |
• | our immediate payment of all principal and accrued interest, if any, if the debt is payable on demand; |
• | our inability to obtain necessary additional financing if the debt contains covenants restricting our ability to obtain such financing while the debt is outstanding; |
• | our inability to pay dividends on our Class A common stock; |
• | using a substantial portion of our cash flow to pay principal and interest on our debt, which will reduce the funds available for dividends on our Class A common stock if declared, expenses, capital expenditures, acquisitions and other general corporate purposes; |
• | limitations on our flexibility in planning for and reacting to changes in our business and in the industry in which we operate; |
• | increased vulnerability to adverse changes in general economic, industry and competitive conditions and adverse changes in government regulation; and |
• | limitations on our ability to borrow additional amounts for expenses, capital expenditures, acquisitions, debt service requirements, execution of our strategy and other purposes and other disadvantages compared to our competitors who have less debt. |
• | solely dependent upon the performance of a single business, property or asset, or |
• | dependent upon the development or market acceptance of a single or limited number of products, processes or services. |
• | a limited availability of market quotations for our securities; |
• | reduced liquidity for our securities; |
• | a determination that our Class A common stock is a “penny stock” which will require brokers trading in our Class A common stock to adhere to more stringent rules and possibly result in a reduced level of trading activity in the secondary trading market for our securities; |
• | a limited amount of news and analyst coverage; and |
• | a decreased ability to issue additional securities or obtain additional financing in the future. |
Public shares |
30,475,000 | |||
Founder shares |
7,618,750 | |||
|
|
|||
Total shares |
38,093,750 | |||
Total funds in trust available for initial business combination |
$ | 310,845,000 | ||
|
|
|||
Initial implied value per public share |
$ | 10.20 | ||
Implied value per share upon consummation of initial business combination |
$ | 8.16 |
• | the history and prospects of companies whose principal business is the acquisition of other companies; |
• | prior offerings of those companies; |
• | our prospects for acquiring an operating business at attractive values; |
• | a review of debt to equity ratios in leveraged transactions; |
• | our capital structure; |
• | an assessment of our management and their experience in identifying operating companies; |
• | general conditions of the securities markets at the time of the Public Offering; and |
• | other factors as were deemed relevant. |
• | costs and difficulties inherent in managing cross-border business operations; |
• | rules and regulations regarding currency redemption; |
• | complex corporate withholding taxes on individuals; |
• | laws governing the manner in which future business combinations may be effected; |
• | exchange listing and/or delisting requirements; |
• | tariffs and trade barriers; |
• | regulations related to customs and import/export matters; |
• | local or regional economic policies and market conditions; |
• | unexpected changes in regulatory requirements; |
• | challenges in managing and staffing international operations; |
• | longer payment cycles; |
• | tax issues, such as tax law changes and variations in tax laws as compared to the United States; |
• | currency fluctuations and exchange controls; |
• | rates of inflation; |
• | challenges in collecting accounts receivable; |
• | cultural and language differences; |
• |
employment regulations; |
• |
underdeveloped or unpredictable legal or regulatory systems; |
• |
corruption; |
• |
protection of intellectual property; |
• |
social unrest, crime, strikes, riots and civil disturbances; |
• |
regime changes and political upheaval; |
• |
terrorist attacks and wars, including the conflict between Russia and Ukraine; and |
• |
deterioration of political relations with the United States. |
• |
due diligence and investigation of prospective target businesses; |
• |
legal and accounting fees relating to our SEC reporting obligations and general corporate matters; |
• |
structuring and negotiating an initial business combination, including the making of a down payment or the payment of exclusivity or similar fees and expenses; and |
• |
other miscellaneous expenses. |
Gross proceeds |
$ |
304,750,000 |
||
Less: |
||||
Proceeds allocated to Public Warrants |
(20,265,875) |
|||
Class A common stock issuance costs |
(16,276,200) |
|||
Plus: |
||||
Accretion of carrying value to redemption value |
42,637,075 |
|||
|
|
|||
Class A common stock subject to possible redemption |
$ |
310,845,000 |
||
|
|
ASSETS: |
||||
Current assets: |
||||
Cash |
$ | |||
Prepaid expenses |
||||
|
|
|||
Total current assets |
||||
Cash and investments held in Trust Account |
||||
|
|
|||
Total Assets |
$ | |||
|
|
|||
LIABILITIES, CLASS A COMMON STOCK SUBJECT TO POSSIBLE REDEMPTION AND STOCKHOLDERS’ DEFICIT: |
||||
Current liabilities: |
||||
Accounts payable and accrued expenses |
$ | |||
Accrued franchise tax |
||||
|
|
|||
Total current liabilities |
||||
Warrant liabilities |
||||
Deferred underwriting compensation |
||||
|
|
|||
Total Liabilities |
||||
|
|
|||
Commitments and Contingencies |
||||
Class A common stock subject to possible redemption; |
||||
Stockholders’ deficit: |
||||
Preferred stock, $ |
||||
Class A common stock, $ |
||||
Class B common stock, $ |
||||
Additional paid-in capital |
||||
Accumulated deficit |
( |
) | ||
|
|
|||
Total Stockholders’ Deficit |
( |
) | ||
|
|
|||
Total Liabilities, Class A Common Stock Subject to Possible Redemption and Stockholders’ Deficit |
$ | |||
|
|
Operating Expenses: |
||||
General and administrative expenses |
$ | |||
Franchise tax expense |
||||
|
|
|||
Loss from operations |
( |
) | ||
Other income (expense): |
||||
Interest earned on investments held in Trust Account |
||||
Change in fair value of warrant liabilities |
||||
Warrant issuance transaction costs |
( |
) | ||
|
|
|||
Income before provision for income taxes |
||||
Provision for income taxes |
||||
|
|
|||
Net income |
$ | |||
|
|
|||
Weighted average shares outstanding of Class A common stock |
||||
|
|
|||
Net income per common stock, Class A - basic and diluted |
$ | |||
|
|
|||
Weighted average shares outstanding of Class B common stock |
||||
|
|
|||
Net income per common stock, Class B - basic and diluted |
$ | |||
|
|
Common Stock |
Additional Paid-in Capital |
Accumulated Deficit |
Total Stockholders’ Deficit |
|||||||||||||||||||||||||
Class A |
Class B |
|||||||||||||||||||||||||||
Shares |
Amount |
Shares |
Amount |
|||||||||||||||||||||||||
Balance at April 22, 2021 (inception) |
$ | $ | $ | $ | $ | |||||||||||||||||||||||
Issuance of common stock to initial stockholder at approximately $ (1) |
— | — | — | |||||||||||||||||||||||||
Excess of cash received over fair value of Private Warrants |
— | — | — | — | — | |||||||||||||||||||||||
Accretion of Class A common stock subject to possible redemption |
— | — | — | — | ( |
) | ( |
) | ( |
) | ||||||||||||||||||
Net income |
— | — | — | — | — | |||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Balance at December 31, 2021 |
$ | $ | $ | $ | ( |
) | $ | ( |
) | |||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) | Shares and the associated amounts have been adjusted to reflect the surrender of |
Cash flows from operating activities: |
||||
Net income |
$ | |||
Adjustments to reconcile net income to net cash used in operating activities: |
||||
Interest income earned on Trust Account |
( |
) | ||
Change in fair value of warrant liabilities |
( |
) | ||
Warrant issuance transaction costs |
||||
Changes in operating assets and liabilities: |
||||
Prepaid expenses |
( |
) | ||
Accounts payable and accrued expenses |
||||
Accrued franchise tax |
||||
|
|
|||
Net cash used in operating activities |
( |
) | ||
|
|
|||
Cash flows from investing activities: |
||||
Principal deposited in Trust Account |
( |
) | ||
|
|
|||
Net cash used in investing activities |
( |
) | ||
|
|
|||
Cash flows from financing activities: |
||||
Proceeds from private placement of warrants |
||||
Proceeds from sale of units in initial public offering |
||||
Payment of underwriters’ discount |
( |
) | ||
Payment of offering costs |
( |
) | ||
Advances received from Promissory note |
||||
Repayment of advances received from Promissory note |
( |
) | ||
|
|
|||
Net cash provided by financing activities |
||||
|
|
|||
Increase in cash during period |
||||
Cash at beginning of period |
||||
|
|
|||
Cash at end of period |
$ | |||
|
|
|||
Supplemental disclosure of non-cash investing and financing activities: |
||||
Deferred underwriting compensation |
$ | |||
Offering costs paid by sponsor in exchange for founder shares |
$ | |||
Deferred offering costs included in accounts payable and accrued expenses |
$ |
As Reported |
Adjustments |
As Restated |
||||||||||
Balance sheet as of September 24, 2021 |
||||||||||||
Total assets |
$ | $ | $ | |||||||||
Total liabilities |
$ | $ | $ | |||||||||
Class A common stock subject to redemption |
$ | $ | $ | |||||||||
Stockholders’ deficit |
||||||||||||
Class B common stock |
$ |
$ |
$ |
|||||||||
Accumulated deficit |
( |
) |
$ |
( |
) |
$ |
( |
) | ||||
Total stockholders’ deficit |
$ | ( |
) | $ | ( |
) | $ | ( |
) |
For The Period from April 22, 2021 (inception) through December 31, 2021 |
||||||||
Class A |
Class B |
|||||||
Basic and diluted net income per share of common stock |
||||||||
Numerator: |
||||||||
Allocation of net income, as adjusted |
$ | $ | ||||||
Denominator: |
||||||||
Basic and diluted weighted average shares outstanding |
||||||||
Basic and diluted net income per share of common stock |
$ | $ |
Gross proceeds |
$ | |||
Less: |
||||
Proceeds allocated to Public Warrants |
( |
) | ||
Class A common stock issuance costs |
( |
) | ||
Plus: |
||||
Accretion of carrying value to redemption value |
||||
|
|
|||
Class A common stock subject to possible redemption |
$ | |||
|
|
Carrying Value |
Gross Unrealized Holding (Loss) |
Quoted Prices in Active Markets (Level 1) |
||||||||||
U.S. Government Treasury Securities as of December 31, 2021 (1) |
$ | $ | ( |
) | $ |
(1) |
Matured on |
• | in whole and not in part; |
• | at a price of $ |
• | upon a minimum of |
• | if, and only if, the last reported sale price of the Common stock equals or exceeds $ |
December 31, 2021 |
||||
Current |
||||
Federal |
$ |
|||
State |
||||
Deferred |
— |
|||
Federal |
||||
State |
||||
Valuation allowance |
( |
) | ||
Income tax provision |
$ |
|||
December 31, 2021 |
||||
Total Deferred tax asset |
||||
Net Operating loss |
$ |
|||
Accrued expense |
||||
Less: Valuation allowance |
( |
) | ||
Net deferred tax assets |
||||
Deferred tax liabilities |
||||
Unrealized (gain) or loss |
||||
Net Deferred tax assets (liabilities) |
$ |
|||
December 31, 2021 |
||||
Statutory Federal income tax rate |
% | |||
Fair value change in warrant liability |
( |
) | ||
Offering costs allocated to warrants |
||||
Change in valuation Allowance |
% | |||
Total tax provision |
% | |||
Level |
December 31, 2021 |
|||||||
Warrant liabilities—Public |
1 | $ | ||||||
Warrant liabilities—Private |
3 | $ |
As of September 24, 2021 |
As of December 31, 2021 |
|||||||
Exercise price |
$ |
$ | ||||||
Stock price |
$ |
$ | ||||||
Volatility for private warrants |
% |
% | ||||||
Term |
||||||||
Risk-free rate |
% |
% | ||||||
Dividend yield |
% |
% | ||||||
Probability of completing Business Combination (1) |
% |
% |
(1) | Estimate based on completed SPAC market data published by third party as of January 10, 2022. |
Level 3 Derivative warrant liabilities at April 22, 2021 (inception) |
$ | |||
Issuance of Public and Private Warrants |
||||
Change in fair value of derivative warrant liabilities |
( |
) | ||
Transfer of Public Warrants to Level 1 |
( |
) | ||
|
|
|||
Level 3 Derivative warrant liabilities at December 31, 2021 |
$ | |||
|
|
(1) | Due to the use of quoted prices in an active market for Public Warrants as of December 31, 2021, the Company had transfers out of Level 3 to Level 1 amounting to $ as of December 31, 2021. The Company deems the transfer between levels to have occurred at the end of the period. |
Name |
Age |
Position | ||||
Joseph R. Ianniello |
54 | Chief Executive Officer and Chairman | ||||
Marc DeBevoise |
45 | President and Vice Chairman | ||||
Andrew R. Sriubas |
53 | Director | ||||
Alan G. Mnuchin |
61 | Director | ||||
Dr. Dana Beth Ardi |
74 | Director | ||||
Pooja Midha |
44 | Director | ||||
Saif Rahman |
43 | Chief Financial Officer | ||||
Gautam Ranji |
51 | Chief Strategy Officer | ||||
Charles Pavlounis |
56 | Chief Business Development Officer | ||||
Dana McClintock |
50 | Chief Communications Officer | ||||
Stephen D. Mirante |
57 | Chief Administrative Officer | ||||
Kelli Raftery |
50 | Chief Marketing Officer | ||||
Maria Corsaro Charon |
44 | Senior Vice President, Mergers and Acquisitions |
• | assisting board oversight of (1) the integrity of our financial statements, (2) our compliance with legal and regulatory requirements, (3) our independent auditor’s qualifications and independence, and (4) the performance of our internal audit function and independent auditors; the appointment, compensation, retention, replacement, and oversight of the work of the independent auditors and any other independent registered public accounting firm engaged by us; |
• | pre-approving all audit and non-audit services to be provided by the independent auditors or any other registered public accounting firm engaged by us, and establishing pre-approval policies and procedures; reviewing and discussing with the independent auditors all relationships the auditors have with us in order to evaluate their continued independence; |
• | setting clear policies for audit partner rotation in compliance with applicable laws and regulations; obtaining and reviewing a report, at least annually, from the independent auditors describing (1) the independent auditor’s internal quality-control procedures and (2) any material issues raised by the most recent internal quality-control review, or peer review, of the audit firm, or by any inquiry or investigation by governmental or professional authorities, within the preceding five years respecting one or more independent audits carried out by the firm and any steps taken to deal with such issues; |
• | meeting to review and discuss our annual audited financial statements and quarterly financial statements with management and the independent auditor, including reviewing our specific disclosures under “Management’s Discussion and Analysis of Financial Condition and Results of Operations”; reviewing and approving any related party transaction required to be disclosed pursuant to Item 404 of Regulation S-K promulgated by the SEC prior to us entering into such transaction; and |
• | reviewing with management, the independent auditors, and our legal advisors, as appropriate, any legal, regulatory or compliance matters, including any correspondence with regulators or government agencies and any employee complaints or published reports that raise material issues regarding our financial statements or accounting policies and any significant changes in accounting standards or rules promulgated by the Financial Accounting Standards Board, the SEC or other regulatory authorities. |
• | reviewing and approving on an annual basis the corporate goals and objectives relevant to our chief executive officer’s compensation, evaluating our chief executive officer’s performance in light of such goals and objectives and determining and approving the remuneration (if any) of our chief executive officer’s based on such evaluation; |
• | reviewing and making recommendations to our board of directors with respect to the compensation, and any incentive compensation and equity based plans that are subject to board approval of all of our other officers; |
• | reviewing our executive compensation policies and plans; |
• | implementing and administering our incentive compensation equity-based remuneration plans; |
• | assisting management in complying with our proxy statement and annual report disclosure requirements; |
• | approving all special perquisites, special cash payments and other special compensation and benefit arrangements for our executive officers and employees; |
• | producing a report on executive compensation to be included in our annual proxy statement; and |
• | reviewing, evaluating and recommending changes, if appropriate, to the remuneration for directors. |
• | each person known by us to be a beneficial owner of more than 5% of our outstanding common stock of, on an as-converted basis; |
• | each of our executive officers and directors; and |
• | all of our executive officers and directors as a group. |
Name and Address of Beneficial Owner (1) |
Number of Shares of Class A Common Stock Beneficially Owned |
Percentage of Outstanding Shares of Class A Common Stock |
Number of Shares of Class B Common Stock Beneficially Owned |
Percentage of Outstanding Shares of Class B Common Stock |
||||||||||||
Argus Sponsor LLC (2)(3) |
— | — | 7,618,750 | 100 | % | |||||||||||
Joseph R. Ianniello (2)(3) |
— | — | 7,618,750 | 100 | % | |||||||||||
Marc DeBevoise |
— | — | — | — | ||||||||||||
Saif Rahman |
— | — | — | — | ||||||||||||
Andrew R. Sriubas |
— | — | — | — | ||||||||||||
Alan G. Mnuchin |
— | — | — | — | ||||||||||||
Dr. Dana Beth Ardi |
— | — | — | — | ||||||||||||
Pooja Midha |
— | — | — | — | ||||||||||||
All Directors and Executive Officers of the Company as a Group (Six Individuals) |
— | — | 7,618,750 | 100 | % | |||||||||||
Kenneth Griffin (4) |
1,820,397 | 6.0 | % | — | — | |||||||||||
Sculptor Capital LP (5) |
1,533,267 | 5.0 | % | — | — |
(1) | Unless otherwise noted, the business address of each of our stockholders listed is 3 Columbus Circle, 24th Floor, New York, NY 10019. |
(2) | Interests shown consist solely of founder shares, classified as Class B common stock. Such shares will automatically convert into shares of Class A common stock at the time of our initial business combination on a one-for-one |
(3) | Argus Sponsor LLC is the record holder of the shares reported herein. Mr. Ianniello is the managing member of Argus Sponsor LLC and has voting and investment discretion with respect to the common stock held of record by Argus Sponsor LLC. Mr. Ianniello disclaims any beneficial ownership of the securities held by Argus Sponsor LLC other than to the extent of any pecuniary interest he may have therein, directly or indirectly. |
(4) | According to Amendment No. 1 to Schedule 13G filed with the SEC on February 14, 2022, Mr. Kenneth Griffin may be deemed the beneficial owner of 1,820,397 shares of Class A common stock with shared voting power and shared dispositive power with respect to such shares and each of Citadel Advisors LLC, Citadel Advisors Holdings LP and Citadel GP LLC may be deemed the beneficial owner of 1,813,043 shares of Class A common stock with shared voting power and shared dispositive power with respect to such shares. The address of the principal business office of each of these stockholders is 131 S. Dearborn Street, 32nd Floor, Chicago, Illinois 60603. |
(5) | According to a Schedule 13G filed with the SEC on March 4, 2021, each of Sculptor Capital LP, Sculptor Capital II LP, Sculptor Capital Holding Corp., Sculptor Capital Holding II LLC and Sculptor Capital Management, Inc. may be deemed the beneficial owner of 1,533,267 shares of Class A common stock with shared voting power and shared dispositive power with respect to such shares. The address of the principal business office of each of these stockholders is 9 West 57 Street, 39 Floor, New York, NY 10019. |
For the Year Ended December 31, 2021 |
||||
Audit Fees (1) |
$ | 54,539 | ||
Audit-Related Fees (2) |
$ | — | ||
Tax Fees (3) |
$ | — | ||
All Other Fees (4) |
$ | 43,025 | ||
Total Fees |
$ | 93,564 |
(1) | Audit Fees. Audit fees consist of fees billed for professional services rendered in connection with our initial public offering and for the audit of our year-end financial statements and services that are normally provided by our independent registered public accounting firm in connection with statutory and regulatory filings. |
(2) | Audit-Related Fees. Audit-related fees consist of fees billed for assurance and related services that are reasonably related to performance of the audit or review of our year-end financial statements and are not reported under “Audit Fees.” These services include attest services that are not required by statute or regulation and consultation concerning financial accounting and reporting standards. |
(3) | Tax Fees. Tax fees consist of fees billed for professional services relating to tax compliance, tax planning and tax advice. |
(4) | All Other Fees. All other fees consist of fees billed for all other services. |
(a) | The following documents are filed as part of this report: |
(1) | Financial Statements |
(2) | Financial Statement Schedule |
(3) | Exhibits |
April 1, 2022 | Argus Capital Corp. | |||||
By: | /s/ Joseph R. Ianniello | |||||
Name: | Joseph R. Ianniello | |||||
Title: | Chief Executive Officer (Principal Executive Officer) |
Name |
Position |
Date | ||
/s/ Joseph R. Ianniello |
Chairman and Chief Executive Officer | April 1, 2022 | ||
Joseph R. Ianniello | (Principal Executive Officer) |
|||
* |
Chief Financial Officer | April 1, 2022 | ||
Saif Rahman | (Principal Financial and Accounting Officer) |
|||
* |
President and Director | April 1, 2022 | ||
Marc DeBevoise | ||||
* |
Director | April 1, 2022 | ||
Andrew R. Sriubas | ||||
* |
Director | April 1, 2022 | ||
Alan G. Mnuchin | ||||
* |
Director | April 1, 2022 | ||
Dr. Dana Beth Ardi | ||||
* |
Director | April 1, 2022 | ||
Pooja Midha |
*By: | /s/ Joseph R. Ianniello | |
Joseph R. Ianniello, Attorney-in-Fact |